Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Shareholder vote
confidence 98%
filed 2026-07-10
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Planet Labs PBC's 2026 Annual Meeting of Stockholders held on July 9, 2026. The filing presents voting results for three proposals: election of three Class II directors (Vijaya Gadde, General John W. Raymond, and Scott Reese), ratification of KPMG LLP as independent auditor, and a non-binding advisory vote on named executive officer compensation. All three proposals passed with substantial majorities. Shareholder vote results are material to investors as they reflect governance outcomes and stakeholder approval of key corporate matters.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-07-10
Item 5.02
Gary Olson, a Board member of CNB Financial Corporation, resigned effective July 31, 2026, for personal reasons with no disagreement with the Company. This is a clear director departure disclosure under Item 5.02. Board resignations are material to investors as they affect governance and oversight structure, particularly at financial institutions where board composition is significant.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 95%
filed 2026-07-10
Item 3.01
LM Funding received a second notification from Nasdaq on July 7, 2026, confirming the company's common stock failed to regain compliance with the $1.00 minimum bid price rule. Nasdaq granted an additional 180-day cure period until January 4, 2027, after which the company's common stock will be delisted if compliance is not achieved.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-07-10
Item 5.03
LM Funding implemented a 1-for-25 reverse stock split, approved by shareholders on June 16, 2026, and effectuated via Certificate of Amendment filed July 9, 2026 and effective July 13, 2026. The reverse split was undertaken to regain compliance with Nasdaq's minimum bid price listing requirement.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 85%
filed 2026-07-10
Item 8.01
Generation Income Properties completed a 1-for-10 reverse stock split effective July 9, 2026, undertaken specifically to regain compliance with Nasdaq Capital Market's minimum bid price requirement of $1.00 per share. The Company disclosed that it was at risk of delisting due to non-compliance with this listing standard and implemented the reverse split as a remedial measure to address this compliance risk.
View raw filing on EDGAR →
6-K
M&A activity
confidence 92%
filed 2026-07-10
Vodafone announces that e& (Emirates Telecommunications Group) has agreed to dispose of its entire shareholding in Vodafone to Vega, an acquisition vehicle owned by the Niel family group. This represents a material change of control in Vodafone's ownership structure. Additionally, the relationship agreement between Vodafone and e& dated May 11, 2023 has been terminated, and e&'s nominee director Hatem Dowidar has resigned from the Board, signaling a significant shift in the company's shareholder composition and governance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-07-10
Item 2.02
Wilson Bank Holding Company disclosed financial results for the first six months of 2026, reporting net income of $43.1 million (up 21.3% year-over-year), diluted earnings per share of $3.50 (up 18.6%), assets of $5.980 billion, and shareholder equity of $613.0 million via a shareholder letter.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 98%
filed 2026-07-10
Item 8.01
Accenture Capital closed the sale of approximately $5 billion in aggregate principal amount of senior notes across five series (floating rate, 4.750%, 5.000%, 5.300%, and 5.600% notes) due 2029–2036, fully guaranteed by Accenture. This is a material debt issuance creating direct financial obligations, disclosed under Item 8.01 (Other Events) with net proceeds of approximately $4.979 billion.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-07-10
Item 8.01
This disclosure announces the implementation of a previously-approved three-for-one forward stock split, with record date of July 6, 2026 and expected effectiveness on or about July 17, 2026. While a stock split is a capital structure event, it is fundamentally a governance matter involving amendment to the certificate of incorporation and reclassification of common stock. The event is material to investors as it affects share count and trading mechanics, though it does not alter economic ownership or create new financial obligations.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-07-10
Item 5.02
The Board approved an amendment to the Corporate Executive Officer Compensation and Benefits Continuation Policy on July 7, 2026, modifying severance and supplemental compensation arrangements for covered executives in connection with a change in control. The amendment reduces benefits by capping supplemental salary payments at 24 months and revises the calculation methodology for supplemental compensation related to forgone bonuses. This is a direct modification of compensatory arrangements for officers and is material to investors assessing executive cost obligations and change-of-control liabilities.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-07-10
Item 5.02
The filing discloses both the resignation of two directors (William M. Goodyear and Mark McGowan) and the appointment of Maria Veltre to the Board, effective immediately on July 10, 2026. While both events are disclosed, the principal action emphasized in the Item 5.02 structure and press release is the appointment of Veltre as a new director, making this an exec_appointment event. The departures are characterized as planned and non-contentious, and the Board reduction is a routine governance adjustment. Veltre's appointment to the Board of a NYSE-listed company is material to investors.
View raw filing on EDGAR →
6-K
Debt Issuance
confidence 85%
filed 2026-07-10
EX-99.1
This exhibit is a First Amending Agreement to a syndicated credit facility that increases the maximum aggregate amount from CAD $210 million to CAD $250 million (a $40 million increase). The amendment modifies the borrower's direct financial obligations under the existing Credit Agreement dated April 28, 2026. While technically an amendment rather than a new issuance, it materially expands the borrower's debt capacity and creates new financial obligations, which falls within the debt_issuance category as it represents a material creation or modification of direct financial obligations. The increase is substantial and would be material to a reasonable investor assessing the registrant's capital structure and leverage.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 92%
filed 2026-07-10
Item 1.01
Dana entered into Amendment No. 8 to its Credit and Guaranty Agreement, creating a new senior secured delayed draw term loan A facility of $500 million, and drew down on the facility to redeem all outstanding 8.500% Senior Notes due 2031 at a redemption price of 104.250% of principal plus accrued interest.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 98%
filed 2026-07-10
Item 3.01
Mercer International received a written notice from Nasdaq on July 9, 2026, that it failed to comply with the minimum bid price requirement of $1.00 per share under Nasdaq Listing Rule 5450(a)(1). Although the notice is non-compliance rather than imminent delisting, the Company has been given a 180-day compliance period to regain compliance, with explicit acknowledgment that "there can be no assurance that the Company will be able to regain compliance within the prescribed time period." This is a classic delisting-risk disclosure under Item 3.01.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-07-10
Item 1.01
Cue Biopharma entered into a Securities Purchase Agreement on July 9, 2026, to issue 1,418,071 shares of common stock at $33.21 per share and pre-funded warrants to purchase 87,500 additional shares in a private placement, raising approximately $50.0 million from accredited investors including Cormorant Asset Management and Columbia Threadneedle Investments under Section 4(a)(2) and Rule 506 exemptions.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 92%
filed 2026-07-10
Item 5.02
The Board granted restricted stock units (RSUs) to executive officers (Shao-Lee Lin, Sumita Ray, Michael Meluzio) and non-employee directors on July 9, 2026, pursuant to the 2026 Stock Incentive Plan approved at the most recent shareholder meeting.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-07-10
Item 5.07
This Item 5.07 disclosure reports the final results of the Annual Meeting of Stockholders held on July 9, 2026, including voting outcomes for three proposals: (i) election of eight directors, (ii) ratification of Deloitte & Touche LLP as independent auditor, and (iii) advisory approval of named executive officer compensation. The detailed vote tallies for each director and proposal are provided, which is the core content of a shareholder vote results disclosure.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-07-10
Item 1.01
Public Storage entered into an underwriting agreement for the issuance of $900 million in senior notes across two tranches (2032 and 2036 maturities). This is a material creation of direct financial obligations through debt issuance, disclosed under Item 1.01 as a material definitive agreement. The company intends to use proceeds for the pending National Storage Affiliates Trust acquisition, debt repayment, and general corporate purposes.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 93%
filed 2026-07-10
Item 1.01
La Rosa Holdings entered into a Securities Purchase Agreement on July 10, 2026, to issue 250 shares of Series E Convertible Preferred Stock at $1,000 per share to an institutional investor under Rule 506(b) of Regulation D. The Series E Preferred Stock carries conversion rights into common stock at a conversion price of $1.58 per share with anti-dilution provisions, materially affecting existing shareholders through conversion and dilution mechanics.
View raw filing on EDGAR →
8-K
Governance Other
confidence 72%
filed 2026-07-10
Item 5.03
The Board approved filing a Certificate of Designation for 10,000 shares of Series E Preferred Stock in connection with the equity issuance, representing a material amendment to the Company's capital structure and articles of incorporation.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-07-10
EX-99.1
This is a press release dated July 10, 2026, announcing Tokyo Lifestyle Co., Ltd.'s fiscal year 2026 financial results for the period ended March 31, 2026. The exhibit discloses comprehensive financial metrics including revenue ($373.2 million, up 77.6% YoY), gross profit, operating income, net income, and earnings per share, along with detailed management commentary on business performance and strategy. This is a classic earnings release event disclosing annual financial results.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-07-10
EX-99.1
This exhibit discloses BitFuFu's June 2026 operational metrics and strategic updates, including Bitcoin production (125 BTC), hashrate capacity (15.3 EH/s), and capital deployment plans (acquisition of 3,200 S21 XP units and 5.3 EH/s of third-party hashrate). While not a formal earnings release with GAAP financials, the disclosure of material operational metrics, significant capital commitments, and strategic initiatives (hashrate expansion, share repurchase program) would affect a reasonable investor's assessment of the company's operational trajectory and capital allocation discipline.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 92%
filed 2026-07-10
The 6-K discloses the appointment of Wesley Chu as an independent director, chairman of the compensation committee, and member of the audit and nominating committees, effective July 10, 2026. While the filing also mentions the concurrent resignation of Qi Ding, the principal disclosed action is Chu's appointment to the Board with specific committee assignments and compensation. The appointment is material as it affects board composition and governance structure, particularly in the context of the Company's stated intention to increase U.S.-based board representation.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-07-10
The 6-K discloses results of an annual general meeting of shareholders held on July 10, 2026, with detailed voting tallies for six proposals. The most material proposals are the approval of a dual-class share structure (Proposals 3 and 4) and authorization for share consolidation (Proposal 5), which fundamentally alter the Company's capital structure and voting rights. All proposals passed with overwhelming majorities (99.87%–99.93% approval). This is a classic shareholder_vote_results disclosure under Item 5.07 equivalent, and the structural changes are material to investors.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-07-10
The 6-K discloses results of an Extraordinary General Meeting of Shareholders held on July 8, 2026, with detailed voting tallies for five proposals: (1) Share Capital Increase from US$78,125 to US$37,500,000; (2) Amended and Restated Memorandum; (3) Share Consolidations up to 4000:1 ratio; (4) General Authorization for implementation; and (5) Adjournment. All proposals were approved with overwhelming majorities (97% quorum). The Share Capital Increase and Share Consolidations are material capital structure changes that would affect a reasonable investor's assessment of share ownership and dilution.
View raw filing on EDGAR →
6-K
Governance Other
confidence 85%
filed 2026-07-10
EX-99.1
Masonglory Ltd called an extraordinary general meeting for July 31, 2026, to seek shareholder approval of significant governance and capital structure changes: an 8-for-1 share consolidation, creation of dual-class shares with Class B shares carrying 50 votes per share versus 1 vote for Class A shares, and adoption of amended memorandum and articles of association. These structural changes materially affect shareholder voting rights and capital structure.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-07-10
Item 2.01
Olenox Industries acquired 100% of the issued and outstanding shares of Psylinks Neurotech Corp. on July 3, 2026, for US$500,000 in restricted common stock, making Psylinks a wholly owned subsidiary and expanding the Company's strategic presence in neurotechnology and applied intelligence platforms.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 94%
filed 2026-07-10
Item 1.01
Cyabra completed a $6.0 million private placement on July 9, 2026, issuing 1,175,090 common shares, pre-funded warrants to purchase 12,643,680 shares, and Series A and B warrants to purchase 13,818,770 shares each, together with conversion of 35.6 million preferred shares into common stock equivalents and exchange of $10.66 million in Series C preferred stock for private placement securities. The transaction substantially dilutes existing shareholders through unregistered equity issuance under Section 4(a)(2) and Regulation D, with significant warrant overhang representing a material capital structure adjustment.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-07-10
Item 1.01
InMed entered into Amendment No. 1 to its merger agreement with Mentari Therapeutics on July 6, 2026, amending the definitive merger agreement dated May 19, 2026 to clarify transaction sequencing, financing mechanics, and tax treatment. The all-stock merger constitutes a change of control and is expected to close in Q4 2026, subject to shareholder approval and other customary conditions.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-07-10
Item 5.02
James J. Ferguson III, Chief Medical Officer, resigned effective July 31, 2026. The disclosure centers on the departure itself—the principal action is a named executive officer leaving his position. While the filing mentions ongoing separation negotiations, the core event is the resignation announcement, making exec_departure the most salient classification.
View raw filing on EDGAR →
6-K
Financial Other
confidence 85%
filed 2026-07-10
EX-99.1
BW LPG announces the sale of the vessel BW Elm by its 52%-owned subsidiary BW LPG India, expected to generate approximately US$36 million in net book gain and US$64 million in net cash proceeds. This is a material asset disposition that affects the company's financial position and cash flow, but does not fit the specific `ma_activity` category (which typically applies to acquisitions, mergers, or changes of control) nor other discrete event types. The sale is a significant financial transaction that would affect a reasonable investor's assessment of the company's capital allocation and fleet composition.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 92%
filed 2026-07-10
The 6-K discloses a $1 million unregistered securities issuance under Section 4(a)(2) and Regulation D Rule 506(b), consisting of 1,000 convertible preferred shares and 1,089,918 ordinary warrants. This is a dilutive private placement to a single investor (Alpha Capital Anstalt) that will increase outstanding share count and dilute existing shareholders upon conversion and warrant exercise. The filing explicitly notes anti-dilution adjustments affecting previously issued preferred shares, indicating material capital structure impact.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 98%
filed 2026-07-10
Item 3.01
Lakeside Holding received a second notice from Nasdaq on July 9, 2026, indicating failure to comply with the minimum bid price requirement of $1.00 per share under Nasdaq Listing Rule 5550(a)(2). While the Company has been granted an additional 180-day compliance period until January 4, 2027, the disclosure explicitly states that if compliance cannot be demonstrated by that date, "the Staff will provide written notification that the Company's securities will be delisted." This is a classic delisting-risk disclosure under Item 3.01, materially affecting investor assessment of the registrant's continued listing status.
View raw filing on EDGAR →
6-K
Governance Other
confidence 85%
filed 2026-07-10
The 6-K discloses shareholder approval on July 7, 2026, at the 2026 Annual General Meeting to increase authorized share capital from approximately 3.3 million to 50 million Class A ordinary shares—a 14-fold increase. This is a governance event (shareholder vote on capitalization) that materially affects the company's capital structure and future dilution potential, though it does not fit the specific `shareholder_vote_results` category (which typically reports vote outcomes on discrete proposals like director elections or compensation plans). The increase in authorized shares is a material structural change that would affect investor assessment of dilution risk.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-07-10
Item 1.01
On July 9, 2026, Faraday Future entered into an Amended and Restated Securities Purchase Agreement materially restructuring the terms of its July 2025 financing ($82 million convertible notes). The amendment restructures the second closing into eight separate tranches tied to $5 million funding milestones, eliminates warrant issuances for most investors, removes registration obligations, and includes termination of warrant agreements cancelling 5.36 million warrants (with cumulative warrant cancellations of approximately 49.9 million shares since 2025), materially reducing shareholder dilution and reshaping the company's capital structure and financing obligations.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 95%
filed 2026-07-10
EX-99.1
This exhibit is a Securities Purchase Agreement dated July 10, 2026, under which VisionSys AI Inc is offering up to $91,750,000 of Ordinary Shares (represented by ADSs) at USD 0.000734 per share to multiple purchasers. The agreement explicitly relies on Section 4(a)(2) of the Securities Act and Regulation S exemptions from registration, indicating an unregistered private placement. This is a material dilutive issuance of equity securities to raise capital outside the registered public market.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 95%
filed 2026-07-10
Helport AI entered into an at-the-market (ATM) sales agreement with Lake Street Capital Markets on July 10, 2026, permitting the company to offer and sell up to $9,550,000 of ordinary shares. This is a dilutive equity issuance under Rule 415(a)(4) of the Securities Act, structured as an ATM offering. The agreement grants the sales agent a 3.0% commission and customary indemnification rights, and the shares are registered under Form F-3 (Registration Number 333-294622). Such capital-raising activities are material to investors assessing the registrant's financing strategy and potential shareholder dilution.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-07-10
Item 1.01
The filing discloses entry into a letter agreement modifying a Common Stock Purchase Agreement with Roth Principal Investments dated June 30, 2026. The adjustment of the purchase price discount to 5.0% of VWAP for pre- and post-market purchases indicates a private equity investment involving issuance of common stock at a discount to market price. This is a classic dilutive issuance structure typical of PIPE or equity financing arrangements, material to investors assessing capital structure and shareholder dilution.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 75%
filed 2026-07-10
The filing discloses the consummation of Viking Acquisition Corp. II's initial public offering on July 6, 2026, involving the issuance of 23,000,000 units at $10.00 per unit ($230 million gross proceeds) and 610,000 private placement units ($6.1 million gross proceeds). While this is technically an IPO rather than a private placement, the core event is the creation of new equity securities (units, ordinary shares, and warrants) that dilute existing shareholders. The private placement component (610,000 units to the Sponsor and underwriter Cohen) is explicitly unregistered under Section 4(a)(2) of the Securities Act, fitting the dilutive_issuance category. The IPO itself, though registered, represents a material capital-raising event through equity issuance.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 82%
filed 2026-07-10
Item 5.02
HeartSciences amended the employment agreement of Danielle Watson (CFO) and granted her 25,000 RSUs in connection with a pending merger. The amendments modify severance provisions (six months base salary, COBRA, 100% acceleration of unvested equity), add discretionary performance bonus eligibility, and establish vesting conditions tied to the merger closing and continued employment.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-07-10
Item 1.01
This Item 1.01 discloses entry into a material definitive agreement—specifically, a second amendment to the Business Combination Agreement between Plum IV and Controlled Thermal Resources Holdings Inc. The amendment materially modifies the merger consideration (reducing valuation from $4.5B to $3.15B), earnout structure (reducing from 100M to 70M shares), and closing timeline (extending to April 30, 2027). These are substantive changes to a material acquisition transaction that would significantly affect investor assessment of the deal's economics and timing.
View raw filing on EDGAR →
8-K
Governance Other
confidence 75%
filed 2026-07-10
Item 8.01
The disclosure centers on a listing compliance issue: NYSE American advised that the Acquisition and Line of Credit trigger Section 712 stockholder approval requirements because the Conversion Shares equal 20% or more of outstanding shares. The Company cancelled 1,013,637 Conversion Shares on July 10, 2026 to regain compliance pending shareholder approval. While the underlying M&A activity occurred earlier, this Item 8.01 disclosure is primarily a governance event—a shareholder approval requirement and listing compliance matter—rather than the M&A activity itself (which was disclosed in the June 5 8-K).
View raw filing on EDGAR →
8-K
Delisting risk
confidence 95%
filed 2026-07-10
Item 8.01
The filing discloses that Nasdaq notified the Company on May 21, 2026, that it was no longer in compliance with the minimum stockholders' equity requirement for continued listing on The Nasdaq Capital Market. Although the Company raised $4.2 million in a July 1, 2026 offering and believes it now satisfies the requirement, Nasdaq will continue monitoring compliance, and the Company "may be subject to delisting" if it does not evidence compliance by its September 30, 2026 Form 10-Q. This is a classic delisting-risk disclosure under Item 3.01 principles, disclosed here under Item 8.01.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-07-10
Item 1.01
Silo Pharma entered into securities purchase agreements on July 9, 2026, for a private placement of 619,965 shares of common stock (or pre-funded warrants), Series A-3 and A-4 warrants, raising approximately $4 million upfront with potential additional proceeds of ~$7.7 million upon warrant exercise. The unregistered securities were issued under Section 4(a)(2) and Regulation D exemptions, with a registration rights agreement for resale.
View raw filing on EDGAR →
6-K
Debt Issuance
confidence 95%
filed 2026-07-10
Royal Bank of Canada issued $2.3 billion in aggregate principal amount of Senior Global Medium-Term Notes across three tranches (4.652% fixed/floating due 2029, floating rate due 2029, and 4.950% fixed/floating due 2032) pursuant to its shelf registration statement. This constitutes creation of direct financial obligations and is a material debt issuance event.
View raw filing on EDGAR →
6-K
M&A activity
confidence 95%
filed 2026-07-10
EX-99.1
This news release announces that independent proxy advisory firms (including ISS) have recommended shareholders vote FOR an arrangement resolution approving Equinox Gold's acquisition of all issued and outstanding common shares of Orla under a court-approved plan of arrangement dated May 12, 2026. The disclosure concerns a material acquisition/change of control transaction, with the special shareholder meeting scheduled for July 22, 2026. This is a discrete M&A event requiring shareholder approval, not a periodic report or routine governance matter.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-07-10
EX-99.1
BTQ announced completion of the design of a next-generation QCIM + PUF security chip in collaboration with ICTK, with production preparation underway and test chips expected by year-end. This represents a material operational and product-development milestone for a quantum-security semiconductor company, reflecting progress on a key commercialization pathway. While not a discrete M&A transaction, earnings event, or governance matter, it is a significant strategic product milestone that would affect a reasonable investor's assessment of BTQ's execution and market positioning in quantum-era security semiconductors.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-07-10
Nu Holdings announces that its Mexican subsidiary Nubank México has received final Operations Authorization from the CNBV to commence operations as a multiple bank, completing a transformation process first announced in April 2025. This represents a material operational and regulatory milestone enabling expansion of credit, payments, and savings products in Mexico, a key market for the company's growth strategy.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-07-10
The 6-K discloses the election of Mr. Alessandro de Castro Melo to the position of Chief Engineering, Technology and Innovation Officer by the Board of Directors on July 10, 2026. This is a material executive appointment to a named officer position, approved by the Board following recommendation by the People and Organization Committee, with a term extending to 2028.
View raw filing on EDGAR →
6-K
Dividend Distribution
confidence 95%
filed 2026-07-10
The 6-K body discloses a Board of Directors approval of a distribution of Interest on Equity (a form of dividend under Brazilian law) in the gross amount of R$ 2,000,000,000.00 (approximately R$ 1,650,000,000.00 net after tax withholding), with per-share amounts specified for common, preferred, and unit holders. The distribution is material to shareholders and investors as it represents a significant capital return and affects the total mix of information about the registrant's capital allocation and shareholder returns.
View raw filing on EDGAR →